Myo‐inositol in Down syndrome amniotic fluid. A case‐control study. (5th July 2014) - Santamaria, Angelo
Abstract What's already known about this topic? Myo‐inositol is involved in metabolic changes that characterize Down syndrome What does this study add? This study shows that Down syndrome metabolic changes occur very early in the fetal life, with amniotic fluid myo‐inositol concentrations increasing since the mid‐trimester. A possible clinical use of this finding maybe interesting.